3DSecret kicked off in the last week of February in Braga – Portugal, under the coordination of INL – International Iberian Nanotechnology Laboratory together with the other remaining partners and teams. The event was a hybrid event, in which the consortium met and discussed the challenges and strategies for the project and how we will work together to leverage novel microfluidic platforms to isolate CTCs and, following their culture into 3D spheroids, enable their multi-parametric analysis.
The 3DSecret consortium has been designed in its multidisciplinarity to perfectly match the proposal’s objectives and involves 3 European countries (PT, ES, IT) and one associated country (UK) During the two days of the kick-off, teams were able to present the people involved in the 3DSecret project, their technologies and knowledge.
3DSecret is funded through the EIC Pathfinder Open 2022. The EIC has been established under the EU Horizon Europe programme. It has a budget of €10.1 billion to support game-changing innovations throughout the lifecycle from early-stage research, to proof of concept, technology transfer, and the financing and scale-up of start-ups and SMEs.
This unique project is coordinated by Dr Sara Abalde-Cela, a Staff Researcher at the INL – International Iberian Nanotechnology Laboratory since 2019. She works within the Medical Devices group, and her research focuses on the development of optofluidic platforms for the diagnosis and monitoring of cancer. Mainly, she applies Raman spectroscopy as an interrogation technique to develop novel biosensors, mostly directed to the detection of single cells and metastasis underlying mechanisms.
New updates will be shared here – www.3dsecret.eu